Ozlem Ozgur Gursoy1, Hulusi Goktug Gurer1, Ceren Yildiz Eren1, Pinar Erdogan Ozgur2, Huseyin Gursoy3. 1. Department of Obstetrics and Gynecology, Eskisehir Acibadem Hospital, Eskisehir, Turkey. 2. Department of Pediatrics and Neonatology, Eskisehir Acibadem Hospital, Eskisehir, Turkey. 3. Department of Ophthalmology, Eskisehir Osmangazi University Medical Faculty, Turkey, Eskisehir. hhgursoy@hotmail.com.
Abstract
PURPOSE: To analyze the effects of various obstetric and perinatal factors on the severity of retinopathy of prematurity (ROP). METHODS: Infants born at ≤ 32 weeks of gestation, with less than 1500 g gestational weight and having at least stage 1 ROP, were reviewed. Group1A included treatment-requiring ROP (TR-ROP), and group 2A included the remaining patients not requiring treatment. Group 1B included stage 3 ROP cases, and group 2B included the remaining stage 2 or 1 ROP cases. Group 1C included cases with zone III disease, and group 2C the remaining. The control group (group C) was composed of premature infants without ROP. The multiple comparisons were made among groups 1A, 2A, and C; 1B, 2B, and C; 1C, 2C, and C. RESULTS: A total of 311 infants were included. Group 1A included 34 cases, group 1B 60, group 1C 51, and group C 98. Antenatal steroid administration, gestational diabetes mellitus (GDM), gestational weight (GW), gestational age (GA), sepsis, continuous positive airway pressure (CPAP) time, and invasive mechanical ventilation (MV) time were associated with TR-ROP, stage 3 ROP, and zone I, and II disease (p < 0.05). Pregestational diabetes mellitus (DM) was only associated with stage 3 ROP (p = 0.031). Gestational hypertension was only associated with zone I and II disease (p = 0.034). The use of low-molecular-weight heparin may be protective against stage 3 disease (p = 0.031). CONCLUSION: Antenatal steroid administration, GDM, GW, GA, sepsis, CPAP time, and invasive MV time were risk factors for TR-ROP and stage 3 ROP, while pregestational DM was only associated with stage 3 ROP.
PURPOSE: To analyze the effects of various obstetric and perinatal factors on the severity of retinopathy of prematurity (ROP). METHODS: Infants born at ≤ 32 weeks of gestation, with less than 1500 g gestational weight and having at least stage 1 ROP, were reviewed. Group1A included treatment-requiring ROP (TR-ROP), and group 2A included the remaining patients not requiring treatment. Group 1B included stage 3 ROP cases, and group 2B included the remaining stage 2 or 1 ROP cases. Group 1C included cases with zone III disease, and group 2C the remaining. The control group (group C) was composed of premature infants without ROP. The multiple comparisons were made among groups 1A, 2A, and C; 1B, 2B, and C; 1C, 2C, and C. RESULTS: A total of 311 infants were included. Group 1A included 34 cases, group 1B 60, group 1C 51, and group C 98. Antenatal steroid administration, gestational diabetes mellitus (GDM), gestational weight (GW), gestational age (GA), sepsis, continuous positive airway pressure (CPAP) time, and invasive mechanical ventilation (MV) time were associated with TR-ROP, stage 3 ROP, and zone I, and II disease (p < 0.05). Pregestational diabetes mellitus (DM) was only associated with stage 3 ROP (p = 0.031). Gestational hypertension was only associated with zone I and II disease (p = 0.034). The use of low-molecular-weight heparin may be protective against stage 3 disease (p = 0.031). CONCLUSION: Antenatal steroid administration, GDM, GW, GA, sepsis, CPAP time, and invasive MV time were risk factors for TR-ROP and stage 3 ROP, while pregestational DM was only associated with stage 3 ROP.
Authors: Linda A Cernichiaro-Espinosa; Francisco J Olguin-Manriquez; Andree Henaine-Berra; Gerardo Garcia-Aguirre; Hugo Quiroz-Mercado; Maria A Martinez-Castellanos Journal: Int Ophthalmol Date: 2016-01-14 Impact factor: 2.031
Authors: Saif Aldeen AlRyalat; Khaled Al Oweidat; Ahmed Al-Amer; Ahmad Khader; Abdulla Ajaj; Zeyad Alessa; Allaa Roto Journal: J Neonatal Perinatal Med Date: 2020
Authors: Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang Journal: Surv Ophthalmol Date: 2018-04-19 Impact factor: 6.048
Authors: Cheuk-Ling Yim; Matthew Tam; Hiu-Lam Chan; Shu-Min Tang; Sunny C L Au; Wilson W K Yip; Simon T C Ko; Shi Song Rong; Li Jia Chen; Danny Siu-Chun Ng; Jason C S Yam Journal: Br J Ophthalmol Date: 2018-04-09 Impact factor: 4.638
Authors: Priscilla Y L Chan; Shu-Min Tang; Sunny C L Au; Shi-Song Rong; Henry H W Lau; Simon T C Ko; Danny S C Ng; Li Jia Chen; Jason C S Yam Journal: Sci Rep Date: 2016-08-05 Impact factor: 4.379
Authors: Maria Silvana Galantuomo; Maurizio Fossarello; Alberto Cuccu; Roberta Farci; Markus N Preising; Birgit Lorenz; Pietro Emanuele Napoli Journal: Clin Ophthalmol Date: 2016-11-25